Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple MyelomaAurore Perrot, Jill Corre, Valérie Lauwers‐Cancès et al.|Journal of Clinical Oncology|2019Cited by 179
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic riskJill Corre, Hervé Avet‐Loiseau, Murielle Roussel et al.|Haematologica|2019Cited by 90
Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factorAnaïs Schavgoulidze, Jill Corre, Alexis Talbot et al.|Blood|2022Cited by 64
Exome sequencing identifies germline variants in DIS3 in familial multiple myelomaMaroulio Pertesi, Bertrand Joly, Maxime Vallée et al.|Leukemia|2019Cited by 47
Improved survival in multiple myeloma during the 2005–2009 and 2010–2014 periodsJill Corre, Aurore Perrot, Cyrille Hulin et al.|Leukemia|2021Cited by 41